コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in the two diabetic groups (with and without alpha-lipoic acid).
2 s produced by the oxidative stress scavenger alpha-lipoic acid.
3 le vitamins biotin and pantothenic acid, and alpha-lipoic acid.
4 inistration, a high-fat diet with or without alpha-lipoic acid (1.65 g/kg) was given to the mice and
7 receiving diets supplemented with or without alpha-lipoic acid (400 mg/kg) for 11 months of diabetes.
8 this deficit is dose-dependently reversed by alpha-lipoic acid, a change associated with an improveme
9 ar weights, and molar-mass dispersities from alpha-lipoic acid, a commercially available and renewabl
10 culture medium with 100, 200, or 500 microM alpha-lipoic acid, a metabolic antioxidant, after inocul
12 melatonin, a naturally occurring indole, and alpha-lipoic acid, a naturally occurring dithiol, were a
15 OxPhos deficit in cINs could be reversed by Alpha Lipoic Acid/Acetyl-L-Carnitine (ALA/ALC) but not b
17 fold and 70%, respectively, in diabetes, and alpha-lipoic acid administration inhibited these increas
21 Treating A-T cells with the antioxidant, alpha lipoic acid (ALA), restored mitochondrial respirat
23 to synthesize a new UV active derivative of alpha-lipoic acid (ALA) by its esterification with 4-met
24 ts with a racemic mixture of the antioxidant alpha-lipoic acid (ALA) could improve glucose metabolism
27 ination of mixed tocopherols (666 IU/d) plus alpha-lipoic acid (ALA; 600 mg/d) or matching placebos f
29 f several antioxidant agents (ascorbic acid, alpha-lipoic acid, alpha-tocopherol, Mn(III)-tetrakis(4-
32 mitochondria, lipoic acid synthase produces alpha-lipoic acid, an antioxidant and an essential cofac
33 dduct formation in human liver microsomes by alpha-lipoic acid, an inhibitor of NADPH: p450 reductase
34 l function and arborization were reversed by alpha lipoic acid and acetyl-L-carnitine treatments, whi
35 entation with the mitochondrial antioxidants alpha-lipoic acid and coenzyme Q(10) also suppresses Bak
36 ut normalized by treatment with antioxidants alpha-lipoic acid and D-alpha-tocopherol and, surprising
38 l derivatives of potent antioxidant vitamin, alpha-lipoic acid, and related analogues were designed,
41 under aqueous miniemulsion conditions using alpha-lipoic acid as a cheap and scalable building block
45 systemic treatment with either HC-030031 or alpha-lipoic acid could completely prevent hypersensitiv
46 aining vitamin C, vitamin E, zinc, selenium, alpha-lipoic-acid, cranberry extract, grapeseed extract,
48 tration of either insulin or the antioxidant alpha-lipoic acid decreased proteinuria and oxidative st
53 n of the cell culture medium with 100 microM alpha-lipoic acid for 72 h after infection prevented the
54 -doped carbon dots (Tb@N-CDs), combined with alpha-lipoic acid-functionalized copper nanoclusters (LA
58 nstrate that the long-term administration of alpha-lipoic acid has beneficial effects on the developm
60 rovide further evidence for the potential of alpha-lipoic acid in treatment of diseases related to ox
61 We report that the nutritional supplement alpha-lipoic acid inhibits cystine stone formation in th
64 r 0.2% (wt/vol) in drinking water], and/or R-alpha-lipoic acid (LA) [0.2% or 0.1% (wt/wt) in diet].
65 e shown previously that the dithiol compound alpha-lipoic acid (LA) exerts antiinflammatory effects b
70 d with the antioxidants vitamin E (VE) and R-alpha-lipoic acid (LA) in streptozotocin-induced diabeti
73 hombencephalic neurons and co-treatment with alpha-lipoic acid (LA) or one of several other antioxida
74 ed that 2 mo of dietary supplementation with alpha-lipoic acid (LA) prevented early glomerular injury
75 ects of administration of the antioxidant DL-alpha-lipoic acid (LA) to streptozotocin-injected diabet
76 statistical and block copolymers containing alpha-lipoic acid (LA) using reversible addition-fragmen
78 ate whether dietary supplementation with (R)-alpha-lipoic acid (LA) was effective at reducing oxidati
79 rter (hSMVT) has been suggested to transport alpha-lipoic acid (LA), a potent antioxidant and anti-in
82 ranslocation, old rats were treated with (R)-alpha-lipoic acid (LA; 40 mg/kg i.p. up to 48 h), a disu
83 % (wt/vol) in the drinking water] and/or (R)-alpha-lipoic acid [LA, 0.5% (wt/wt) in the chow] improve
84 yielding 600 g of poly(n-butyl acrylate-stat-alpha-lipoic acid) latexes that degrade under reducing c
85 ants regulated Ang II receptors differently: alpha-Lipoic acid lowered Ang II binding after 24 h, and
86 e retina is impaired and may be corrected by alpha-lipoic acid (LPA), a drug that inhibits vascular h
87 s for immediate testing in progressive MS: R-alpha-lipoic acid, metformin, the combination treatment
88 tioxidants ascorbate, ascorbate 2-phosphate, alpha-lipoic acid, N-acetyl-L-cysteine and glutathione i
89 iabetic rats, treatment with the antioxidant alpha-lipoic acid normalized the amount of leukostasis b
90 e of this study was to examine the effect of alpha-lipoic acid on retinal capillary cell apoptosis an
92 acid, Trolox, Resveratrol, Alpha tocopherol, Alpha lipoic acid, Orotic acid, Ginsenoside RB1, and Xan
93 of drugs, choline (CHO), idebenone (IDB), R-alpha-lipoic acid plus acetyl-L-carnitine (LCLA), was fo
97 supplementation of old animals with 0.5% (R)-alpha-lipoic acid prior to cell isolation almost complet
98 he antioxidants epigallocatechin gallate and alpha-lipoic acid reduces polyglutamine aggregation.
99 % or greater responder rate, flunarizine and alpha-lipoic acid (risk ratio [RR], 8.73; 95% CI, 2.44-3
100 ncubation with the AMPK activators AICAR and alpha-lipoic acid substantially prevented all of those c
101 nd their nondiabetic apoE(-/-) controls with alpha-lipoic acid supplement than in those without it.
110 of acrolein and the protective effects of R-alpha-lipoic acid were examined with a variety of previo
111 Dihydrolipoic acid (the reduced form of alpha-lipoic acid), which contains free sulfhydryl group
112 receptor binding in cell membranes, whereas alpha-lipoic acid, which does not contain free sulfhydry